These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38875880)

  • 1. Offering nurse care management for opioid use disorder in primary care: Impact on emergency and hospital utilization in a cluster-randomized implementation trial.
    Bobb JF; Idu AE; Qiu H; Yu O; Boudreau DM; Wartko PD; Matthews AG; McCormack J; Lee AK; Campbell CI; Saxon AJ; Liu DS; Altschuler A; Samet JH; Northrup TF; Braciszewski JM; Murphy MT; Arnsten JH; Cunningham CO; Horigian VE; Szapocznik J; Glass JE; Caldeiro RM; Tsui JI; Burganowski RP; Weinstein ZM; Murphy SM; Hyun N; Bradley KA
    Drug Alcohol Depend; 2024 Aug; 261():111350. PubMed ID: 38875880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PRimary Care Opioid Use Disorders treatment (PROUD) trial protocol: a pragmatic, cluster-randomized implementation trial in primary care for opioid use disorder treatment.
    Campbell CI; Saxon AJ; Boudreau DM; Wartko PD; Bobb JF; Lee AK; Matthews AG; McCormack J; Liu DS; Addis M; Altschuler A; Samet JH; LaBelle CT; Arnsten J; Caldeiro RM; Borst DT; Stotts AL; Braciszewski JM; Szapocznik J; Bart G; Schwartz RP; McNeely J; Liebschutz JM; Tsui JI; Merrill JO; Glass JE; Lapham GT; Murphy SM; Weinstein ZM; Yarborough BJH; Bradley KA
    Addict Sci Clin Pract; 2021 Jan; 16(1):9. PubMed ID: 33517894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nurse Care Management for Opioid Use Disorder Treatment: The PROUD Cluster Randomized Clinical Trial.
    Wartko PD; Bobb JF; Boudreau DM; Matthews AG; McCormack J; Lee AK; Qiu H; Yu O; Hyun N; Idu AE; Campbell CI; Saxon AJ; Liu DS; Altschuler A; Samet JH; Labelle CT; Zare-Mehrjerdi M; Stotts AL; Braciszewski JM; Murphy MT; Dryden D; Arnsten JH; Cunningham CO; Horigian VE; Szapocznik J; Glass JE; Caldeiro RM; Phillips RC; Shea M; Bart G; Schwartz RP; McNeely J; Liebschutz JM; Tsui JI; Merrill JO; Lapham GT; Addis M; Bradley KA; ; Ghiroli MM; Hamilton LK; Hu Y; LaHue JS; Loree AM; Murphy SM; Northrup TF; Shmueli-Blumberg D; Silva AJ; Weinstein ZM; Wong MT; Burganowski RP
    JAMA Intern Med; 2023 Dec; 183(12):1343-1354. PubMed ID: 37902748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baseline representativeness of patients in clinics enrolled in the PRimary care Opioid Use Disorders treatment (PROUD) trial: comparison of trial and non-trial clinics in the same health systems.
    Wartko PD; Qiu H; Idu AE; Yu O; McCormack J; Matthews AG; Bobb JF; Saxon AJ; Campbell CI; Liu D; Braciszewski JM; Murphy SM; Burganowski RP; Murphy MT; Horigian VE; Hamilton LK; Lee AK; Boudreau DM; Bradley KA
    BMC Health Serv Res; 2022 Dec; 22(1):1593. PubMed ID: 36581845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study protocol for a pragmatic trial of the Consult for Addiction Treatment and Care in Hospitals (CATCH) model for engaging patients in opioid use disorder treatment.
    McNeely J; Troxel AB; Kunins HV; Shelley D; Lee JD; Walley A; Weinstein ZM; Billings J; Davis NJ; Marcello RK; Schackman BR; Barron C; Bergmann L
    Addict Sci Clin Pract; 2019 Feb; 14(1):5. PubMed ID: 30777122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addressing identification bias in the design and analysis of cluster-randomized pragmatic trials: a case study.
    Bobb JF; Qiu H; Matthews AG; McCormack J; Bradley KA
    Trials; 2020 Mar; 21(1):289. PubMed ID: 32293514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid Overdose After Medication for Opioid Use Disorder Initiation Following Hospitalization or ED Visit.
    Weiner SG; Little K; Yoo J; Flores DP; Hildebran C; Wright DA; Ritter GA; El Ibrahimi S
    JAMA Netw Open; 2024 Jul; 7(7):e2423954. PubMed ID: 39037812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementation facilitation to promote emergency department-initiated buprenorphine for opioid use disorder: protocol for a hybrid type III effectiveness-implementation study (Project ED HEALTH).
    D'Onofrio G; Edelman EJ; Hawk KF; Pantalon MV; Chawarski MC; Owens PH; Martel SH; VanVeldhuisen P; Oden N; Murphy SM; Huntley K; O'Connor PG; Fiellin DA
    Implement Sci; 2019 May; 14(1):48. PubMed ID: 31064390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and treatment of opioid use disorders among primary care patients in six health systems.
    Lapham G; Boudreau DM; Johnson EA; Bobb JF; Matthews AG; McCormack J; Liu D; Samet JH; Saxon AJ; Campbell CI; Glass JE; Rossom RC; Murphy MT; Binswanger IA; Yarborough BJH; Bradley KA;
    Drug Alcohol Depend; 2020 Feb; 207():107732. PubMed ID: 31835068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation Facilitation to Promote Emergency Department-Initiated Buprenorphine for Opioid Use Disorder.
    D'Onofrio G; Edelman EJ; Hawk KF; Chawarski MC; Pantalon MV; Owens PH; Martel SH; Rothman R; Saheed M; Schwartz RP; Cowan E; Richardson L; Salsitz E; Lyons MS; Freiermuth C; Wilder C; Whiteside L; Tsui JI; Klein JW; Coupet E; O'Connor PG; Matthews AG; Murphy SM; Huntley K; Fiellin DA
    JAMA Netw Open; 2023 Apr; 6(4):e235439. PubMed ID: 37017967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subthreshold opioid use disorder prevention (STOP) trial: a cluster randomized clinical trial: study design and methods.
    Liebschutz JM; Subramaniam GA; Stone R; Appleton N; Gelberg L; Lovejoy TI; Bunting AM; Cleland CM; Lasser KE; Beers D; Abrams C; McCormack J; Potter GE; Case A; Revoredo L; Jelstrom EM; Kline MM; Wu LT; McNeely J
    Addict Sci Clin Pract; 2023 Nov; 18(1):70. PubMed ID: 37980494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Test of a workforce development intervention to expand opioid use disorder treatment pharmacotherapy prescribers: protocol for a cluster randomized trial.
    Molfenter T; Knudsen HK; Brown R; Jacobson N; Horst J; Van Etten M; Kim JS; Haram E; Collier E; Starr S; Toy A; Madden L
    Implement Sci; 2017 Nov; 12(1):135. PubMed ID: 29141653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Emergency Department Longitudinal Integrated Care (ED-LINC) intervention targeting opioid use disorder: A pilot randomized clinical trial.
    Whiteside LK; Huynh L; Morse S; Hall J; Meurer W; Banta-Green CJ; Scheuer H; Cunningham R; McGovern M; Zatzick DF
    J Subst Abuse Treat; 2022 May; 136():108666. PubMed ID: 34952745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between Hospital Adoption of an Emergency Department Treatment Pathway for Opioid Use Disorder and Patient Initiation of Buprenorphine After Discharge.
    Solomon KT; O'Connor J; Gibbons JB; Kilaru AS; Feder KA; Xue L; Saloner B; Stuart EA; Cole ES; Hulsey E; Meisel Z; Patel E; Donohue JM
    JAMA Health Forum; 2023 Mar; 4(3):e230245. PubMed ID: 36961457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rural access to MAT in Pennsylvania (RAMP): a hybrid implementation study protocol for medication assisted treatment adoption among rural primary care providers.
    Cochran G; Cole ES; Warwick J; Donohue JM; Gordon AJ; Gellad WF; Bear T; Kelley D; DiDomenico E; Pringle J
    Addict Sci Clin Pract; 2019 Aug; 14(1):25. PubMed ID: 31366408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of access barriers and medication acceptability on buprenorphine-naloxone treatment utilization over 2 years: Results from a multisite randomized trial of adults with opioid use disorder.
    Evans EA; Yoo C; Huang D; Saxon AJ; Hser YI
    J Subst Abuse Treat; 2019 Nov; 106():19-28. PubMed ID: 31540607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results From the POINT Pragmatic Randomized Trial: An Emergency Department-Based Peer Support Specialist Intervention to Increase Opioid Use Disorder Treatment Linkage and Reduce Recurrent Overdose.
    Watson DP; Tillson M; Taylor L; Xu H; Ouyang F; Beaudoin FL; O'Donnell D; McGuire AB
    Subst Use Addctn J; 2024 Jul; 45(3):378-389. PubMed ID: 38258819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of a pragmatic clinical trial to improve screening and treatment for opioid use disorder in primary care.
    Rossom RC; Crain AL; O'Connor PJ; Wright E; Haller IV; Hooker SA; Sperl-Hillen JM; Olson A; Romagnoli K; Solberg L; Dehmer SP; Haapala J; Borgert-Spaniol C; Tusing L; Muegge J; Allen C; Ekstrom H; Huntley K; McCormack J; Bart G
    Contemp Clin Trials; 2023 Jan; 124():107012. PubMed ID: 36402275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a Co-Located Bridging Recovery Initiative on Hospital Length of Stay Among Patients With Opioid Use Disorder: The BRIDGE Randomized Clinical Trial.
    Marcovitz D; Dear ML; Donald R; Edwards DA; Kast KA; Le TDV; Shah MV; Ferrell J; Gatto C; Hennessy C; Buie R; Rice TW; Sullivan W; White KD; Van Winkle G; Wolf R; Lindsell CJ;
    JAMA Netw Open; 2024 Feb; 7(2):e2356430. PubMed ID: 38411964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exemplar Hospital initiation trial to Enhance Treatment Engagement (EXHIT ENTRE): protocol for CTN-0098B a randomized implementation study to support hospitals in caring for patients with opioid use disorder.
    Bart G; Korthuis PT; Donohue JM; Hagedorn HJ; Gustafson DH; Bazzi AR; Enns E; McNeely J; Ghitza UE; Magane KM; Baukol P; Vena A; Harris J; Voronca D; Saitz R
    Addict Sci Clin Pract; 2024 Apr; 19(1):29. PubMed ID: 38600571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.